Ascend NTD Learning Session /
The Ascend programme is pleased to invite you to a Learning Session, ‘Learnings from the application of the Risk Assessment and Mitigation Action (RAMA) process’ on 16th December at 12 noon GMT.
The RAMA tool was developed by Sightsavers in collaboration with partners working in NTDs who identified the need for a systematic assessment of the risk posed by the COVID-19 pandemic against the current country specific context. The tool has been adapted and adopted to safeguard the Ascend programme as well as the communities it serves, ensuring a consistent process across Lots 1 and 2. It considers risk of transmission and spread of COVID-19 in country as part of initiating NTD activities, weighing it against strategies in place, or being developed, to mitigate that risk for every stage of an NTD control programme.
Countries within the Ascend programme were supported through application of the RAMA tool. There are similarities and differences in application between countries, which offers key learnings for current and future risk management in national programmes.
The focus of the learning session is on risk management practices to resume NTD activities in the COVID-19 context. It will:
- Explain how Ascend has and is supporting countries with RAMA
- Bring to life country experiences and lessons from the field on RAMA
- Highlight adaptions to the RAMA tool and process from learnings along the way
- Identify any ongoing and foreseeable challenges and potential advantages of RAMA
If you would like to register your interest in the webinar session please email firstname.lastname@example.org
The Accelerating the Sustainable Control and Elimination of Neglected Tropical Diseases (Ascend) Lot 1 programme aims to achieve progress towards global targets for the control and elimination of neglected tropical diseases (NTDs) across Africa and South Asia.
The Lot 1 consortium consists of Crown Agents, KIT Royal Tropical Institute, Oriole Global Health, and Abt Associates.
The Lot 2 consortium consists of Sightsavers, Mott MacDonald, the SCI Foundation and the Liverpool School of Tropical Medicine.